|Articles|August 29, 2019
High-touch services that enhance patient outcomes
Author(s)McKesson Life Sciences
In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
When Drug Pricing Becomes Trade Policy
3
President Trump Set to Nominate Heidi Overton as FDA Commissioner
4
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
5